Table 1.

Patient characteristics.

Characteristic	Cohort 1	Cohort 2	Cohort 3
Mean age in years ± SD	55 (± 14)	51 (± 16)	54 (± 13)
Male/Female	54/36	100/41	19/17
Mean years post KT ± SD	6 (± 7)	5 (± 6)	First year follow-up
KT donor
Living related	20	21	6
Living unrelated	13	28	5
Cadaveric	57	92	25

Demographic details of patients included in statistical analysis. Patients who failed quality control for epigenetic analysis are not show.